World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
49
Citations
8471
World Ranking
4577
National Ranking
1768

Niranjan Y. Sardesai publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Niranjan Y. Sardesai sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 189 publications — 44th percentile

44% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Niranjan Y. Sardesai D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Niranjan Y. Sardesai sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 49 D-Index — 18th percentile

18% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Niranjan Y. Sardesai is affiliated with the University of Pennsylvania in the United States and has contributed extensively to the fields of medicine, immunology, and molecular biology. Their research spans multiple subfields including oncology, immunology, molecular biology, biotechnology, and hepatology, reflecting a diversified interest in biomedical sciences.

Their work primarily focuses on areas such as immunotherapy and immune responses, cancer immunotherapy and biomarkers, CAR-T cell therapy research, vaccines and immunoinformatics approaches, hepatocellular carcinoma treatment and prognosis, transgenic plants and applications, as well as RNA interference and gene delivery.

Frequent coauthors collaborating with the scientist include:

  • Neil Cooch
  • Alfredo Perales-Puchalt
  • Mark Yarchoan
  • Sarah Rochestie
  • David B. Weiner

Their publications have appeared in several scientific venues, with notable repeated contributions to:

  • Regular and Young Investigator Award Abstracts
  • Cancer Research
  • Journal of Clinical Oncology
  • Vaccine Insights
  • Nature Medicine

Some recent published papers by Niranjan Y. Sardesai include:

  • Personalized neoantigen vaccine and pembrolizumab in advanced hepatocellular carcinoma: a phase 1/2 trial, 2024, Nature Medicine
  • Robust antibody and cellular responses induced by DNA-only vaccination for HIV, 2020, JCI Insight
  • Intramuscular and Intradermal Electroporation of HIV-1 PENNVAX-GP® DNA Vaccine and IL-12 Is Safe, Tolerable, Acceptable in Healthy Adults, 2020, Vaccines
  • A synDNA vaccine delivering neoAg collections controls heterogenous, multifocal murine lung and ovarian tumors via robust T cell generation, 2021, Molecular Therapy - Oncolytics
  • Personalized Neoantigen Vaccine and Pembrolizumab in Advanced Hepatocellular Carcinoma: A phase 1/2 trial, 2024, immuneACCESS

Best Publications

  • Safety, efficacy, and immunogenicity of VGX-3100, a therapeutic synthetic DNA vaccine targeting human papillomavirus 16 and 18 E6 and E7 proteins for cervical intraepithelial neoplasia 2/3: a randomised, double-blind, placebo-controlled phase 2b trial.

    Cornelia L Trimble;Matthew P Morrow;Kimberly A Kraynyak;Xuefei Shen

  • Electroporation delivery of DNA vaccines: prospects for success

    Niranjan Y Sardesai;David B Weiner

  • Immunotherapy Against HPV16/18 Generates Potent TH1 and Cytotoxic Cellular Immune Responses

    Mark L. Bagarazzi;Jian Yan;Matthew P. Morrow;Xuefei Shen

  • A synthetic consensus anti–spike protein DNA vaccine induces protective immunity against Middle East respiratory syndrome coronavirus in nonhuman primates

    Karuppiah Muthumani;Darryl Falzarano;Emma L. Reuschel;Colleen Tingey

  • Safety and Comparative Immunogenicity of an HIV-1 DNA Vaccine in Combination with Plasmid Interleukin 12 and Impact of Intramuscular Electroporation for Delivery

    Spyros A. Kalams;Scott D. Parker;Marnie Elizaga;Barbara Metch

  • Immunogenicity of novel consensus-based DNA vaccines against Chikungunya virus.

    Karuppiah Muthumani;Katthikbabu M. Lankaraman;Dominick J. Laddy;Senthil G. Sundaram;Senthil G. Sundaram

  • A DNA vaccine against chikungunya virus is protective in mice and induces neutralizing antibodies in mice and nonhuman primates.

    Karthik Mallilankaraman;Devon J. Shedlock;Huihui Bao;Omkar U. Kawalekar

  • MESOMARK™: A Potential Test for Malignant Pleural Mesothelioma

    Heather L. Beyer;Ryan D. Geschwindt;Curtis L. Glover;Ly Tran

  • Heterosubtypic Protection against Pathogenic Human and Avian Influenza Viruses via In Vivo Electroporation of Synthetic Consensus DNA Antigens

    Dominick J. Laddy;Jian Yan;Michele Kutzler;Darwyn Kobasa

  • Personalized neoantigen vaccine and pembrolizumab in advanced hepatocellular carcinoma: a phase 1/2 trial

    Unknown

  • Mesothelin Variant 1 Is Released from Tumor Cells as a Diagnostic Marker

    Ingegerd Hellstrom;John Raycraft;Sandra Kanan;Niranjan Y. Sardesai

  • In vivo protection against ZIKV infection and pathogenesis through passive antibody transfer and active immunisation with a prMEnv DNA vaccine

    Karuppiah Muthumani;Bryan D Griffin;Bryan D Griffin;Sangya Agarwal;Sagar B Kudchodkar

  • Intradermal SynCon® Ebola GP DNA Vaccine Is Temperature Stable and Safely Demonstrates Cellular and Humoral Immunogenicity Advantages in Healthy Volunteers

    Pablo Tebas;Kimberly A Kraynyak;Ami Patel;Joel N Maslow

  • Multivalent Smallpox DNA Vaccine Delivered by Intradermal Electroporation Drives Protective Immunity in Nonhuman Primates Against Lethal Monkeypox Challenge

    Lauren A. Hirao;Ruxandra Draghia-Akli;Jonathan T. Prigge;Maria Yang

  • Development of a novel DNA SynCon tetravalent dengue vaccine that elicits immune responses against four serotypes.

    Mathura P. Ramanathan;Yuan-Chia Kuo;Bernard H. Selling;Qianjun Li

  • Tolerability of intramuscular and intradermal delivery by CELLECTRA(®) adaptive constant current electroporation device in healthy volunteers.

    Malissa C Diehl;Jessica C Lee;Stephen E Daniels;Pablo Tebas

  • DNA Recognition by Peptide Complexes of Rhodium(III): Example of a Glutamate Switch

    Niranjan Y. Sardesai;Kaspar Zimmermann;Jacqueline K. Barton

  • The p40 Subunit of Interleukin (IL)-12 Promotes Stabilization and Export of the p35 Subunit IMPLICATIONS FOR IMPROVED IL-12 CYTOKINE PRODUCTION

    Rashmi Jalah;Margherita Rosati;Brunda Ganneru;Guy R. Pilkington

  • A human immune data-informed vaccine concept elicits strong and broad T-cell specificities associated with HIV-1 control in mice and macaques

    Beatriz Mothe;Xintao Hu;Anuska Llano;Margherita Rosati

  • DNA vaccination protects mice against Zika virus-induced damage to the testes.

    Bryan D. Griffin;Bryan D. Griffin;Kar Muthumani;Bryce M. Warner;Bryce M. Warner;Anna Majer

  • Immunogenicity of Novel Consensus-Based DNA Vaccines Against Chikungunya Virus

    K. Muthumani;K. Lankaraman;D. Laddy;S. Sundaram

Frequent Co-Authors

David B. Weiner
David B. Weiner The Wistar Institute
Karuppiah Muthumani
Karuppiah Muthumani The Wistar Institute
Barbara K. Felber
Barbara K. Felber National Institutes of Health
George N. Pavlakis
George N. Pavlakis Emory University
Jean D. Boyer
Jean D. Boyer Inovio Pharmaceuticals (United States)
David C. Montefiori
David C. Montefiori Duke University
Gary Kobinger
Gary Kobinger The University of Texas Medical Branch at Galveston
James I. Mullins
James I. Mullins University of Washington
Kenneth E. Ugen
Kenneth E. Ugen University of South Florida
Celia C. LaBranche
Celia C. LaBranche Duke University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Microbiology in the USA opens doors to a variety of related healthcare careers and specialized education paths. One key area is advancing into nursing roles, such as becoming a Functional Medicine Nurse Practitioner. Numerous functional medicine nurse practitioner programs provide comprehensive training that integrates microbiology knowledge with holistic patient care.

For those interested in the administrative side of health, careers in medical coding and health information management offer promising opportunities. The role of a Certified Professional Coder is pivotal in managing patient data and ensuring accurate billing. Prospective students can explore insights on certified professional coder salary and career outlook to gauge the benefits of this pathway.

Similarly, Health Information Managers play a crucial role in overseeing medical records and data systems. Exploring the health information management jobs salary and career trajectories can help students understand the financial and professional rewards of this field.

To pursue these roles, obtaining a recognized degree is essential. Accredited programs, such as the best online health information management degree cahiim accredited courses, offer flexible learning options that meet industry standards and prepare graduates for successful careers.

Best Scientists Citing Niranjan Y. Sardesai

Trending Scientists

Recently Published Articles